中国医学创新
中國醫學創新
중국의학창신
Medical Innovation of China
2015年
31期
107-110
,共4页
辐照%悬浮红细胞%单采血小板%输血相关性移植物抗宿主病
輻照%懸浮紅細胞%單採血小闆%輸血相關性移植物抗宿主病
복조%현부홍세포%단채혈소판%수혈상관성이식물항숙주병
Irradiation%Suspension red blood cells%Apheresis platelet%Transfusion-associated graft-versus-host disease
目的：探讨分析辐照血液成分的临床用量及所占比例。方法：统计分析青岛地区2010-2014年辐照血液成分的临床用血量及占总用血量的比例，对比分析近几年辐照血液成分比例变化。结果：青岛地区近5年临床用血量中辐照红细胞类成分占红细胞类总用血量的0.91%，辐照血小板类占血小板总用量的7.40%。与前两年相比，近3年辐照血液成分占总用血量的比例大幅增加。结论：随着对TA-GVHD认识的进一步深入，临床对辐照血液成分的重视程度加大，辐照血液成分的使用量也不断增加。
目的：探討分析輻照血液成分的臨床用量及所佔比例。方法：統計分析青島地區2010-2014年輻照血液成分的臨床用血量及佔總用血量的比例，對比分析近幾年輻照血液成分比例變化。結果：青島地區近5年臨床用血量中輻照紅細胞類成分佔紅細胞類總用血量的0.91%，輻照血小闆類佔血小闆總用量的7.40%。與前兩年相比，近3年輻照血液成分佔總用血量的比例大幅增加。結論：隨著對TA-GVHD認識的進一步深入，臨床對輻照血液成分的重視程度加大，輻照血液成分的使用量也不斷增加。
목적：탐토분석복조혈액성분적림상용량급소점비례。방법：통계분석청도지구2010-2014년복조혈액성분적림상용혈량급점총용혈량적비례，대비분석근궤년복조혈액성분비례변화。결과：청도지구근5년림상용혈량중복조홍세포류성분점홍세포류총용혈량적0.91%，복조혈소판류점혈소판총용량적7.40%。여전량년상비，근3년복조혈액성분점총용혈량적비례대폭증가。결론：수착대TA-GVHD인식적진일보심입，림상대복조혈액성분적중시정도가대，복조혈액성분적사용량야불단증가。
Objective:To analyze the clinical application and the proportion of irradiated red blood cell components.Method: The clinical application in irradiation blood components of Qingdao from 2010 to 2014 were statistical analyzed,the irradiated blood composition changes in recent years were compared and analyzed.Result:Nearly the five years, the percentage of irradiated red blood cells in the total clinical usage was 0.91%,and the percentage of irradiated aphaeresis platelet in the total clinical usage was 7.40%. Compared with the previous two years, a big increasion in the clinical usage of irradiated red blood cell components in the nearly three years.Conclusion:Along with the further understanding of TA-GVHD,clinical doctors pay more attention to the application in irradiation blood components and the use of irradiation blood components also increased.
